Effects of GDHT (Goal Directed Hemodynamic Therapy) Using a Non-invasive Hemodynamic Monitoring in Elective Neurosurgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrno University Hospital

About this trial

This study aims to assess the safety and efficacy of GDHT using the non-invasive Starling™ SV System in elective neurosurgery. The tested group of patients (n=70) will be compared with a control group (n=70), where hemodynamic management will be guided by standard vital signs monitoring.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Elective brain surgery with an expected duration ≥ 2 h

Category 1-3 according to the ASA (American Society of Anesthesiologists) Physical Status Classification

Lateral or supine operative position

Disqualifiers

Category 4 according to the ASA Physical Status Classification

Surgery for traumatic brain injury or acute hemorrhagic stroke

Awake brain surgery

Osmotherapy before surgery (with the exception of prophylactic administration of osmotic agents according to institutional standards)

Trial design

Treatments tested in this trial

  • Standard monitoring
  • Goal-Directed Therapy

Treatment groups

140 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Brno University Hospital

Lead sponsor

Military University Hospital, Prague

Collaborator

Zlin Regional Hospital

Collaborator